Blood markers glossary: key terms explained

Table of Content

Blood markers and a comprehensive glossary to understand them
Medically Reviewed by: Julien Priour

⚕️ This article is for informational purposes only and does not replace medical advice. Always consult your doctor to interpret your results.

A blood test report can feel like it was written in another language. This blood markers glossary breaks down the terms you are most likely to see on a lab report, grouped by the type of panel they come from, so you can find what you need quickly. Each entry gives a short, plain-language definition rather than a technical one, and wherever AI DiagMe has a full guide on a specific marker, the term links directly to it for deeper reading. Use this page as a reference you can return to every time a new abbreviation shows up on your results, and always bring genuine questions back to your doctor, who knows your full clinical picture.

Complete blood count (CBC) markers

The complete blood count looks at the three main cell types in your blood: red cells, white cells, and platelets. These markers help detect anemia, infection, and clotting risk.

TermDefinition
Complete blood count (CBC)A single test that counts and describes red blood cells, white blood cells, and platelets, giving an overall snapshot of blood health.
Red blood cells (RBC)The cells that carry oxygen from your lungs to the rest of your body; a low count often points toward anemia.
Hemoglobin (Hb)The iron-rich protein inside red blood cells that actually binds and transports oxygen.
Hematocrit (Hct)The percentage of your total blood volume made up of red blood cells.
MCV (mean corpuscular volume)The average size of red blood cells; larger cells suggest B12 or folate deficiency, smaller cells suggest low iron.
White blood cells (WBC)Immune cells that defend against infection; a high count often signals infection or inflammation.
NeutrophilsThe most common white blood cell type and the first line of defense against bacterial infections.
LymphocytesWhite blood cells central to fighting viral infections and building long-term immune memory.
PlateletsSmall cell fragments that clump together to stop bleeding when a blood vessel is injured.
MPV (mean platelet volume)The average size of platelets, offering clues about how actively they are being produced.
FerritinA protein that stores iron inside cells; low levels signal deficiency, while high ferritin levels can reflect iron overload or inflammation.

Metabolic panel and glucose markers

Metabolic panels measure blood sugar, electrolytes, and how your body manages energy. These markers are central to diagnosing and monitoring diabetes and prediabetes.

TermDefinition
Fasting blood glucoseA measurement of blood sugar taken after at least eight hours without food, used to screen for and diagnose diabetes or prediabetes.
HbA1c (glycated hemoglobin)A marker that reflects your average blood sugar level over the past two to three months, used to diagnose and monitor diabetes.
InsulinA hormone made by the pancreas that helps cells absorb glucose from the blood for energy or storage.
HOMA-IRA calculated score, based on fasting glucose and fasting insulin, that estimates how well your cells respond to insulin.
SodiumAn electrolyte that helps regulate fluid balance and nerve signaling; levels are tightly controlled by the kidneys.
PotassiumA mineral essential for normal heart rhythm and muscle function; both very high and very low levels can be serious.
Bicarbonate (CO2)A marker of your blood’s acid-base balance, reflecting how well your lungs and kidneys regulate pH.

Liver markers

Liver markers reveal whether liver cells are under strain and whether bile is flowing normally. Doctors read them together as a pattern rather than one number at a time.

TermDefinition
ALT (alanine aminotransferase / SGPT)An enzyme found mainly inside liver cells; it rises when liver cells are inflamed or damaged, making it a fairly specific liver marker.
AST (aspartate aminotransferase)An enzyme found in the liver, heart, and muscles; high levels often suggest liver damage but can also reflect muscle injury.
ALP (alkaline phosphatase)An enzyme found mostly in the liver and bones; elevated levels can point to bile duct problems or bone conditions.
GGT (gamma-glutamyl transferase)A liver and bile duct enzyme that is highly sensitive for detecting bile flow problems and is also affected by alcohol intake.
Bilirubin (total)A yellow pigment formed when red blood cells break down; high levels can cause jaundice and may signal liver or bile duct issues.
AlbuminThe main protein made by the liver, important for fluid balance and transporting hormones and drugs through the blood.
PrealbuminA liver-made protein that changes faster than albumin, making it useful for assessing recent nutritional status.
Total proteinsThe combined amount of all proteins in the blood, used as a broad screening tool for liver and kidney health.

Lipid panel markers

A lipid panel measures the fats circulating in your blood, giving a picture of your cardiovascular risk.

TermDefinition
Total cholesterolThe sum of all cholesterol types in your blood; a high level can raise the risk of heart and blood vessel disease.
LDL cholesterolOften called “bad cholesterol,” LDL can deposit into artery walls and contribute to plaque buildup when levels are high.
HDL cholesterolOften called “good cholesterol,” HDL carries excess cholesterol away from the arteries back to the liver for removal.
TriglyceridesA type of blood fat created from unused calories; high levels are linked to heart disease and, at very high levels, pancreatitis.
Apolipoprotein B (apoB)A protein found on LDL and related particles; it counts the number of potentially artery-clogging particles and is increasingly used alongside LDL cholesterol.

Kidney function markers

Kidney markers are waste products that healthy kidneys filter out of the blood. Measuring them is the main way to assess how well your kidneys are working.

TermDefinition
CreatinineA waste product from normal muscle activity that healthy kidneys filter out steadily; higher levels can suggest slower filtering.
eGFR (estimated glomerular filtration rate)A calculated estimate, based on creatinine, age, and sex, of how much blood your kidneys filter each minute.
BUN (blood urea nitrogen)A measure of urea, a waste product from protein breakdown; high levels can point to reduced kidney filtering or dehydration.
Urine creatinineThe amount of creatinine excreted in urine, used to help calculate ratios like the albumin-to-creatinine ratio and assess kidney function.
Uric acidA waste product cleared by the kidneys; elevated levels are linked to gout and, sometimes, reduced kidney clearance.

Coagulation and clotting markers

These markers assess how your body forms and dissolves blood clots. A healthy balance prevents both excessive bleeding and dangerous clot formation.

TermDefinition
D-dimerA protein fragment released when a blood clot dissolves; a high level can suggest recent significant clot activity, such as in deep vein thrombosis.
aPTT (activated partial thromboplastin time)A test measuring how long it takes blood to clot through one part of the clotting cascade, often used to monitor heparin therapy.
Prothrombin time (PT)A test measuring how long it takes blood plasma to clot through a different part of the clotting cascade, often reported alongside the INR.
INR (international normalized ratio)A standardized calculation from the PT test, mainly used to monitor anticoagulant drugs like warfarin.
Antithrombin IIIA natural anticoagulant protein that helps prevent excessive clotting; low levels raise the risk of thrombosis.
Protein CA natural anticoagulant protein that helps limit clot formation; a deficiency increases the risk of abnormal blood clots.
Protein SA protein that works alongside Protein C to regulate clotting; low levels raise the risk of thrombosis.
Vitamin KA fat-soluble vitamin required to activate several clotting factors in the liver; its effect is usually measured through the PT and INR.

Hormone and endocrine markers

Hormone markers reveal how your glands are communicating with the rest of your body, from metabolism to stress response.

TermDefinition
TSH (thyroid-stimulating hormone)A pituitary hormone that signals the thyroid to make more or less hormone; it is usually the first test used to screen thyroid function.
Free T4The active, unbound form of thyroxine, one of the two main thyroid hormones, used to confirm a TSH result.
CortisolA stress hormone made by the adrenal glands that affects blood sugar, blood pressure, and the immune response.
TestosteroneThe primary male sex hormone, also present in smaller amounts in women, involved in muscle mass, bone density, and libido.

Inflammation and infection markers

These markers rise when the body detects inflammation, injury, or infection anywhere in the body.

TermDefinition
CRP (C-reactive protein)A protein made by the liver that rises quickly in response to inflammation anywhere in the body, used to detect infection or inflammatory conditions.
hs-CRP (high-sensitivity CRP)A more sensitive version of the CRP test, mainly used in cardiology to assess long-term cardiovascular risk from low-grade inflammation.
ESR (erythrocyte sedimentation rate)A test measuring how quickly red blood cells settle in a tube, used as a general, non-specific sign of inflammation.
TroponinA protein found almost exclusively in heart muscle cells; its release into the blood is a specific and sensitive sign of cardiac injury.

Vitamins, minerals and tumor markers

This final group covers nutritional markers and the substances used to help monitor certain cancers.

TermDefinition
Vitamin B12A vitamin essential for nerve function and red blood cell production; deficiency can cause fatigue and large red blood cells.
Vitamin DA vitamin that supports bone health and calcium absorption; low levels are common and often go unnoticed without testing.
CalciumA mineral vital for bones, nerves, and muscle function, tightly regulated by hormones including parathyroid hormone and vitamin D.
MagnesiumA mineral involved in hundreds of bodily reactions, including muscle and nerve function and heart rhythm.
Tumor markersSubstances measured in blood, urine, or tissue that can offer clues about cancer; they are mainly used to monitor known cancers rather than to screen healthy people.
PSA (prostate-specific antigen)A protein used to monitor, and sometimes screen for, prostate conditions including cancer; levels can also rise from harmless causes.
CEA (carcinoembryonic antigen)A marker often used to monitor colorectal and some other cancers, particularly for signs of recurrence after treatment.

Latest scientific advances

Laboratory medicine keeps refining how existing markers are measured and interpreted, often years before those changes reach everyday lab reports. A few developments from the past two years stand out across different categories in this glossary.

In lipid testing, the American Heart Association published clinical guidance in 2024 clarifying how apolipoprotein B (apoB) should be used alongside LDL cholesterol for cardiovascular risk assessment. ApoB can outperform LDL cholesterol at predicting atherosclerotic risk because it directly counts potentially artery-damaging particles rather than estimating their cholesterol content, and the review proposes clearer treatment thresholds for clinicians (Circulation, 2024) (DOI).

In cardiac marker testing, a 2025 review from the Italian Study Group on Cardiac Biomarkers examined refinements to high-sensitivity cardiac troponin assays, including how small, progressive rises below the diagnostic cutoff may still carry cardiovascular risk information (Clinical Chemistry and Laboratory Medicine, 2025) (DOI).

In coagulation testing, a 2023 meta-analysis pooling 68 studies and over 140,000 patients evaluated strategies for adjusting D-dimer cutoff levels, including age-based adjustments, to reduce unnecessary imaging while safely ruling out venous thromboembolism. Adjusted thresholds meaningfully improved specificity over a single fixed cutoff, though performance varied across strategies (Journal of Internal Medicine, 2023) (DOI).

Beyond the panels covered here, blood-based biomarkers for Alzheimer’s disease have advanced quickly. A 2024 report from the Global CEO Initiative on Alzheimer’s Disease outlined clinical pathways for using blood tests to triage patients and eventually confirm amyloid pathology, a shift that could enable earlier, more accessible screening as new treatments become available (Alzheimer’s & Dementia, 2024) (DOI).

Together, these advances point to a broader trend: markers are increasingly interpreted as part of a pattern, adjusted for individual factors, and combined with other data rather than read as a single isolated number.

Frequently asked questions

What is a normal blood marker range?

A normal range, also called a reference range, is the span of values a laboratory considers typical for a healthy population. Ranges vary between labs and often depend on your age and sex. A result outside this range is a starting point for discussion with your doctor, not automatically a sign of disease.

How often should I get blood tests?

It depends on your age, health history, and any known conditions. Many healthy adults have routine panels like a CBC or metabolic panel checked once a year, while people managing a chronic condition may need more frequent testing. Your doctor can set the right schedule for you.

Why do different labs show different reference ranges for the same marker?

Laboratories use different equipment, reagents, and reference populations to set their ranges. This is why it is important to always compare your result to the range printed on your own report, not a number from another source or a previous lab.

Can one abnormal blood marker mean I have a serious condition?

Not usually. A single abnormal result is often explained by everyday factors like dehydration, recent exercise, or minor illness. Doctors typically look at the whole panel and whether the result repeats on a follow-up test before drawing conclusions.

Do I need to fast before a blood test?

It depends on which markers are being measured. Fasting glucose and a lipid panel usually require 8 to 12 hours without food, while many others, including a standard CBC or thyroid panel, do not require fasting. Always follow your doctor’s or laboratory’s instructions.

What is the difference between a blood marker and a biomarker?

A biomarker is any measurable biological sign of health or disease, from blood, urine, tissue, or other sources. A blood marker is simply a biomarker measured in a blood sample. Every term in this glossary is a blood marker, and most fall under the broader category of biomarkers.

Sources

  • MedlinePlus (National Library of Medicine, NIH) — Lab Tests
  • Centers for Disease Control and Prevention (CDC) — Testing for Chronic Kidney Disease
  • National Cancer Institute (NCI) — Tumor Markers
  • Joshi PH, et al. “Apolipoprotein B: Bridging the Gap Between Evidence and Clinical Practice.” Circulation, 2024 (DOI)
  • Clerico A, et al. “Advancements and challenges in high-sensitivity cardiac troponin assays.” Clinical Chemistry and Laboratory Medicine, 2025 (DOI)
  • Gerber JL, et al. “Utility and limitations of patient-adjusted D-dimer cut-off levels for diagnosis of venous thromboembolism.” Journal of Internal Medicine, 2023 (DOI)
  • Mielke MM, et al. “Recommendations for clinical implementation of blood-based biomarkers for Alzheimer’s disease.” Alzheimer’s & Dementia, 2024 (DOI)

Further reading

Understanding your lab results shouldn’t require a medical degree. AI DiagMe reads your blood test report and explains each marker in plain language, helping you prepare clearer questions for your doctor. Get your results interpreted in minutes.

Author

  • AI DiagMe

    The AI DiagMe team brings together physicians, clinical specialists, and medical editors. Our articles are written by health communication professionals and then reviewed and validated by the physicians of our scientific committee, composed of practicing hospital physicians in specialties such as hematology, endocrinology, and general medicine. Julien Priour, who leads the editorial mission, holds an MBA from HEC Paris and was trained in scientific writing and publishing by the French National Research Institute for Sustainable Development (IRD, FUN-MOOC, 2026). Each piece of content is based on current clinical guidelines and peer-reviewed medical publications.

Related Posts